Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several...

Regulatory oversight of emerging technologies in the case of developing countries has historically been a touché topic. Primarily because regulation per se is seen as unfriendly to business ventures entering as yet uncharted areas of technological evolution that holds a promise of positive...

Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several...

The burgeoning generic drugs and pharmaceuticals sector in India is one of the foremost industrial sectors of the new economy in India along with the IT sector. The growing manufacturing capacity of the health sector in concomitants with the aggressive international expansion strategies through...

With the setting up of a dedicated public research program in nanotechnology (through the nano mission) in May 2007, the state support for nanotechnology R amp; D in India has become institutionalized. This has enabled nanotechnology to assume a privileged position within the public policy...

The nanotechnology regulatory regime in India, in concomitance with the technology itself, is fast emerging and is marked by new discoveries and their applications across disciplinary fields. Although both are emerging, this dynamism is not a two-way phenomenon; the technological developments...

The precautionary principle is one of the most contentious principles in contemporary international legal developments. The very fact that it is a principle of international environmental law has been questioned by many legal scholars. However, this does not take away the fact that the...

Several international actors have become active in setting up task forces/expert groups and other administrative structures to develop regulatory norms in the context of regulation of nanotechnology and more specifically nanomedicines. Interestingly some of these actors have had international...